Cite
MLA Citation
B Hirsh-Raccah et al.. “Exposure to Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) inhibitors and the association with neurocognitive side effects: a meta-analysis and meta-regression.” European heart journal, vol. 41, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100117806509.0x00004f